To examine liver function and lipid indexes in patients with high myopia and assess their associations with axial length and myopic macular degeneration (MMD), highlighting the significance of these associations.
Key Findings:
High myopia is associated with distinct liver function and lipid metabolism profiles, suggesting systemic health implications.
Lower levels of liver enzymes (ALT, AST, GGT) may correlate with the severity of myopic macular degeneration, indicating a potential biomarker for disease progression.
Altered serum lipid profiles in high myopic patients suggest systemic metabolic disturbances that could impact ocular health.
Interpretation:
The findings suggest a potential liver-eye metabolic axis, indicating that liver function may influence the progression of high myopia and associated ocular complications, possibly through metabolic pathways.
Limitations:
Retrospective design may limit causal inferences and introduce biases.
Exclusion of patients with prior liver disease may affect generalizability.
Liver function tests were not specifically designed for this study, which may limit the specificity of findings.
Conclusion:
This study provides preliminary evidence linking liver function and lipid metabolism to high myopia and myopic macular degeneration, warranting further investigation into the liver-eye metabolic axis and its implications for treatment.
A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.
